AMETEK, Inc. vs Waters Corporation, two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AME and WAT diverge most: on operating margin, AME reads 26.7% and WAT reads -3.7%; on return on invested capital, AME reads 12.2% and WAT reads 2.4%. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AME | WAT |
|---|---|---|
| Price | $241.75 | $377.25 |
| Market cap | $55.6B | $31.0B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Mature | Growth |
| Implied growth (priced in) | +24.8% | — |
| P/E | 36.5 | 47.8 |
| P/B | 5.09 | 2.03 |
| P/S | 7.31 | 8.16 |
| EV/EBITDA | 23.9 | 55.0 |
| Revenue growth | +9.5% | +28.6% |
| Operating margin | 26.7% | -3.7% |
| Net margin | 20.1% | 11.9% |
| Return on equity | 14.0% | 3.0% |
| Return on assets | 9.4% | 1.8% |
| Return on invested capital | 12.2% | 2.4% |
| FCF yield | 3.1% | 1.1% |
| Dividend yield | 0.2% | — |
| Debt / equity | 0.20 | 0.32 |
| Current ratio | 1.14 | 1.79 |
| Altman Z (solvency) | 7.68 | 2.84 |
| Piotroski F (quality) | 7 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.